Groups and diagnosis | No (%) | Neoadjuvant chemo (no, %*) | Adjuvant chemo (no, %*) | 5-year OS, % |
---|---|---|---|---|
GI | 20 (39) | 12 (60) | 11 (55) | 39 |
GIST (stomach, intestine) | 9 | 8 | 8 | |
Pancreas ca | 4 | 1 | 2 | |
Duodenum ca | 2 | 1 | – | |
Esophagus ca | 2 | – | – | |
Anal ca | 3 | 2 | 1 | |
GU | 7 (14) | 4 (57) | 6 (86) | 43 |
Cervix ca | 2 | 2 | 2 | |
Endometrial ca | 2 | – | 1 | |
Uterine sarcoma | 2 | 1 | 2 | |
Ovarian ca | 1 | 1 | 1 | |
Melanoma | 16 (31) | 1 (6) | 7 (44) | 12 |
Ocular | 12 | 1 | 5 | |
Cutaneous | 3 | – | 2 | |
Unknown melanoma | 1 | – | – | |
Breast c-r | 2 (4) | 1 (50) | 2 (100) | NA |
Others | 6 (12) | 0 (0) | 3 (50) | 75 |
Adrenocortical ca | 2 | – | 2 | |
Retroperitoneal sarcoma | 2 | – | – | |
Lung ca | 1 | – | 1 | |
Unknown** | 1 | – | – | |
Total | 51 | 18 (35) | 29 (57) | 38 |